Sign in

CIK 0001811063

  • Non-accelerated filer
  • Smaller reporting company

Nuvation Bio Inc.

Sign in to watch
Ticker
NUVB
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850862255
Phone
+1 332-208-6102
Business address
1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
Former names
Panacea Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-27 Hanley David C. CHIEF TECHNICAL OPERATIONS Grant or award · Stock Option (Right to Buy) +748,130 748,130
2025-11-19 Hanley David C. CHIEF TECHNICAL OPERATIONS Exercise or conversion +200,000 $1.87 $374K 224,000
2025-11-19 Hanley David C. CHIEF TECHNICAL OPERATIONS Sale −200,000 $7.14 $1.4M 24,000
2025-11-19 Hanley David C. CHIEF TECHNICAL OPERATIONS Exercise or conversion · Stock Option (Right to Buy) −200,000 300,000
2025-02-28 Hanley David C. CHIEF TECHNICAL OPERATIONS Grant or award · Stock Option (Right to Buy) +500,000 500,000
2024-02-29 Hanley David C. CHIEF TECHNICAL OPERATIONS Grant or award · Stock Option (Right to Buy) +500,000 500,000
2023-02-28 Hanley David C. Chief Technical Operations Grant or award · Stock Option (Right to Buy) +500,000 500,000
2022-08-29 Hanley David C. Chief Technical Operations Grant or award · Stock Option (Right to Buy) +450,000 450,000
2022-02-28 Hanley David C. Chief Technical Operations Grant or award · Stock Option (Right to Buy) +500,000 500,000
2021-06-01 Hanley David C. Chief Technical Operations Grant or award · Stock Option (Right to Buy) +250,000 250,000
2021-06-01 Hanley David C. Chief Technical Operations Grant or award · Stock Option (Right to Buy) +187,500 187,500

Page 1 of 1 · 11 trades